glp 1 agonist effects GLP-1 Medications: Everything You Need to Know Glucagon-Like Peptide-1: New Regulator in
Description
Holter et al
Review both the anorexigenic and orexigenic pathways
Lancet Diabetes Endocrinol 10(6):418429
c) Kidney Protection By improving blood flow and reducing inflammation, GLP-1 drugs can delay diabetic kidney disease progression
